Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Long Acting Insulins market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Long Acting Insulins market. Detailed analysis of key players, along with key growth strategies adopted by Long Acting Insulins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novo Nordisk A/S
Sanofi SA
Biocon Limited
Eli Lilly and Company
Pfizer Inc
By Type:
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
By End-User:
Home Use
Medical Institutions
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Long Acting Insulins Market
-
1.3 Market Segment by Type
-
1.3.1 China Long Acting Insulins Market Size and Growth Rate of Insulin Glargine from 2016 to 2027
-
1.3.2 China Long Acting Insulins Market Size and Growth Rate of Insulin Determir from 2016 to 2027
-
1.3.3 China Long Acting Insulins Market Size and Growth Rate of Insulin Degludec from 2016 to 2027
-
1.3.4 China Long Acting Insulins Market Size and Growth Rate of Long Acting Animal Insulin from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Long Acting Insulins Market Size and Growth Rate of Home Use from 2016 to 2027
-
1.4.2 China Long Acting Insulins Market Size and Growth Rate of Medical Institutions from 2016 to 2027
-
1.4.3 China Long Acting Insulins Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Long Acting Insulins Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Long Acting Insulins by Major Types
-
3.4.1 Market Size and Growth Rate of Insulin Glargine
-
3.4.2 Market Size and Growth Rate of Insulin Determir
-
3.4.3 Market Size and Growth Rate of Insulin Degludec
-
3.4.4 Market Size and Growth Rate of Long Acting Animal Insulin
4 Segmentation of Long Acting Insulins Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Long Acting Insulins by Major End-Users
-
4.4.1 Market Size and Growth Rate of Long Acting Insulins in Home Use
-
4.4.2 Market Size and Growth Rate of Long Acting Insulins in Medical Institutions
-
4.4.3 Market Size and Growth Rate of Long Acting Insulins in Others
5 Market Analysis by Regions
-
5.1 China Long Acting Insulins Production Analysis by Regions
-
5.2 China Long Acting Insulins Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Long Acting Insulins Landscape Analysis
-
6.1 North China Long Acting Insulins Landscape Analysis by Major Types
-
6.2 North China Long Acting Insulins Landscape Analysis by Major End-Users
7 Central China Long Acting Insulins Landscape Analysis
-
7.1 Central China Long Acting Insulins Landscape Analysis by Major Types
-
7.2 Central China Long Acting Insulins Landscape Analysis by Major End-Users
8 South China Long Acting Insulins Landscape Analysis
-
8.1 South China Long Acting Insulins Landscape Analysis by Major Types
-
8.2 South China Long Acting Insulins Landscape Analysis by Major End-Users
9 East China Long Acting Insulins Landscape Analysis
-
9.1 East China Long Acting Insulins Landscape Analysis by Major Types
-
9.2 East China Long Acting Insulins Landscape Analysis by Major End-Users
10 Northeast China Long Acting Insulins Landscape Analysis
-
10.1 Northeast China Long Acting Insulins Landscape Analysis by Major Types
-
10.2 Northeast China Long Acting Insulins Landscape Analysis by Major End-Users
11 Southwest China Long Acting Insulins Landscape Analysis
-
11.1 Southwest China Long Acting Insulins Landscape Analysis by Major Types
-
11.2 Southwest China Long Acting Insulins Landscape Analysis by Major End-Users
12 Northwest China Long Acting Insulins Landscape Analysis
-
12.1 Northwest China Long Acting Insulins Landscape Analysis by Major Types
-
12.2 Northwest China Long Acting Insulins Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Novo Nordisk A/S
-
13.1.1 Novo Nordisk A/S Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Sanofi SA
-
13.2.1 Sanofi SA Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Biocon Limited
-
13.3.1 Biocon Limited Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lilly and Company
-
13.4.1 Eli Lilly and Company Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Pfizer Inc
-
13.5.1 Pfizer Inc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Long Acting Insulins Market Size and Growth Rate of Insulin Glargine from 2016 to 2027
-
Figure China Long Acting Insulins Market Size and Growth Rate of Insulin Determir from 2016 to 2027
-
Figure China Long Acting Insulins Market Size and Growth Rate of Insulin Degludec from 2016 to 2027
-
Figure China Long Acting Insulins Market Size and Growth Rate of Long Acting Animal Insulin from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Long Acting Insulins Market Size and Growth Rate of Home Use from 2016 to 2027
-
Figure China Long Acting Insulins Market Size and Growth Rate of Medical Institutions from 2016 to 2027
-
Figure China Long Acting Insulins Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Long Acting Insulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Long Acting Insulins Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Long Acting Insulins
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Long Acting Insulins by Different Types from 2016 to 2027
-
Table Consumption Share of Long Acting Insulins by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Insulin Glargine
-
Figure Market Size and Growth Rate of Insulin Determir
-
Figure Market Size and Growth Rate of Insulin Degludec
-
Figure Market Size and Growth Rate of Long Acting Animal Insulin
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Long Acting Insulins by Different End-Users from 2016 to 2027
-
Table Consumption Share of Long Acting Insulins by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Home Use
-
Figure Market Size and Growth Rate of Medical Institutions
-
Figure Market Size and Growth Rate of Others
-
Table China Long Acting Insulins Production by Regions
-
Table China Long Acting Insulins Production Share by Regions
-
Figure China Long Acting Insulins Production Share by Regions in 2016
-
Figure China Long Acting Insulins Production Share by Regions in 2021
-
Figure China Long Acting Insulins Production Share by Regions in 2027
-
Table China Long Acting Insulins Consumption by Regions
-
Table China Long Acting Insulins Consumption Share by Regions
-
Figure China Long Acting Insulins Consumption Share by Regions in 2016
-
Figure China Long Acting Insulins Consumption Share by Regions in 2021
-
Figure China Long Acting Insulins Consumption Share by Regions in 2027
-
Table North China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table North China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure North China Long Acting Insulins Consumption Share by Types in 2016
-
Figure North China Long Acting Insulins Consumption Share by Types in 2021
-
Figure North China Long Acting Insulins Consumption Share by Types in 2027
-
Table North China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table North China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure North China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure North China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure North China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table Central China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table Central China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure Central China Long Acting Insulins Consumption Share by Types in 2016
-
Figure Central China Long Acting Insulins Consumption Share by Types in 2021
-
Figure Central China Long Acting Insulins Consumption Share by Types in 2027
-
Table Central China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table Central China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure Central China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure Central China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table South China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table South China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure South China Long Acting Insulins Consumption Share by Types in 2016
-
Figure South China Long Acting Insulins Consumption Share by Types in 2021
-
Figure South China Long Acting Insulins Consumption Share by Types in 2027
-
Table South China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table South China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure South China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure South China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure South China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table East China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table East China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure East China Long Acting Insulins Consumption Share by Types in 2016
-
Figure East China Long Acting Insulins Consumption Share by Types in 2021
-
Figure East China Long Acting Insulins Consumption Share by Types in 2027
-
Table East China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table East China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure East China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure East China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure East China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table Northeast China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table Northeast China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Long Acting Insulins Consumption Share by Types in 2016
-
Figure Northeast China Long Acting Insulins Consumption Share by Types in 2021
-
Figure Northeast China Long Acting Insulins Consumption Share by Types in 2027
-
Table Northeast China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table Northeast China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure Northeast China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure Northeast China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table Southwest China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table Southwest China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Long Acting Insulins Consumption Share by Types in 2016
-
Figure Southwest China Long Acting Insulins Consumption Share by Types in 2021
-
Figure Southwest China Long Acting Insulins Consumption Share by Types in 2027
-
Table Southwest China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table Southwest China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure Southwest China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure Southwest China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table Northwest China Long Acting Insulins Consumption by Types from 2016 to 2027
-
Table Northwest China Long Acting Insulins Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Long Acting Insulins Consumption Share by Types in 2016
-
Figure Northwest China Long Acting Insulins Consumption Share by Types in 2021
-
Figure Northwest China Long Acting Insulins Consumption Share by Types in 2027
-
Table Northwest China Long Acting Insulins Consumption by End-Users from 2016 to 2027
-
Table Northwest China Long Acting Insulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Long Acting Insulins Consumption Share by End-Users in 2016
-
Figure Northwest China Long Acting Insulins Consumption Share by End-Users in 2021
-
Figure Northwest China Long Acting Insulins Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novo Nordisk A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S
-
Figure Sales and Growth Rate Analysis of Novo Nordisk A/S
-
Figure Revenue and Market Share Analysis of Novo Nordisk A/S
-
Table Product and Service Introduction of Novo Nordisk A/S
-
Table Company Profile and Development Status of Sanofi SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
-
Figure Sales and Growth Rate Analysis of Sanofi SA
-
Figure Revenue and Market Share Analysis of Sanofi SA
-
Table Product and Service Introduction of Sanofi SA
-
Table Company Profile and Development Status of Biocon Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon Limited
-
Figure Sales and Growth Rate Analysis of Biocon Limited
-
Figure Revenue and Market Share Analysis of Biocon Limited
-
Table Product and Service Introduction of Biocon Limited
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
